objectivesto
determin
frequenc
type
respiratori
virus
circul
boston
longterm
care
facil
ltcf
period
designobserv
participantsresid
longterm
care
previous
particip
trial
vitamin
e
supplement
pair
serum
sampl
avail
viral
analysi
measurementsvir
antibodi
titer
eight
respiratori
virus
influenza
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
serotyp
three
human
metapneumoviru
hmpv
coronavirus
measur
use
enzym
immunoassay
baselin
week
infect
defin
quadrupl
viral
titer
clinic
data
respiratori
ill
collect
throughout
studi
period
resultsa
total
person
enrol
trial
sera
avail
viral
analysi
total
viral
infect
document
subject
serolog
respons
eight
virus
document
hmpv
coronaviru
common
least
common
occurr
bronchiti
p
pneumonia
p
lower
respiratori
tract
infect
p
significantli
associ
viral
diagnosi
conclusiona
wide
rang
respiratori
virus
cocircul
ltcf
contribut
respiratori
ill
morbid
popul
keyword
viral
infect
longterm
care
human
metapneumoviru
respiratori
tract
infect
major
caus
morbid
mortal
longterm
care
facil
ltcf
awid
rang
bacteri
viral
pathogen
document
nurs
home
set
although
rel
contribut
specif
pathogen
well
defin
influenza
respiratori
syncyti
viru
rsv
accept
signific
pathogen
popul
role
virus
newli
describ
human
metapneumoviru
hmpv
larg
unexplor
resid
ltcf
risk
nosocomi
spread
respiratori
virus
outbreak
respiratori
ill
uncommon
although
infect
pathogen
young
adult
gener
mild
seriou
complic
may
occur
frail
elderli
person
thu
resid
nurs
home
consid
target
group
antivir
vaccin
although
influenza
remain
import
viral
respiratori
pathogen
popul
determin
type
frequenc
virus
lead
lower
respiratori
infect
lri
nurs
home
may
import
futur
studi
prevent
measur
therapeut
first
step
serum
sampl
avail
vitamin
e
supplement
trial
conduct
larg
number
ltcf
analyz
evid
recent
infect
eight
common
respiratori
virus
viral
diagnos
correl
occurr
respiratori
ill
studi
particip
recruit
ltcf
boston
massachusett
area
period
inclus
criteria
age
older
life
expect
greater
month
room
bound
absenc
activ
cancer
tube
feed
urethr
cathet
tracheostomi
chronic
ventil
depend
longterm
steroid
use
addit
serum
albumin
least
gdl
willing
receiv
influenza
vaccin
requir
tuft
new
england
medic
center
institut
review
board
approv
studi
particip
legal
guardian
provid
inform
consent
year
studi
volunt
enrol
vitamin
e
supplement
trial
intervent
period
serum
sampl
collect
time
enrol
aprilaugust
week
year
supplement
investig
train
studi
nurs
identifi
relev
respiratori
symptom
perform
focus
physic
examin
prospect
surveil
respiratori
ill
conduct
throughout
year
data
nurs
home
medic
record
find
studi
nurs
use
classifi
respiratori
ill
respiratori
tract
infect
categor
accord
standard
definit
includ
common
cold
influenzalik
ill
pharyng
otiti
media
sinus
defin
upper
respiratori
infect
uri
acut
bronchiti
pneumonia
defin
lri
patient
sampl
collect
time
ill
diagnost
microbiolog
enzym
immunoassay
eia
perform
detect
viralspecif
immunoglobulin
g
eight
respiratori
virus
influenza
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
serotyp
three
human
metapneumoviru
hmpv
coronavirus
accord
publish
method
briefli
antigen
produc
viral
infect
wholecel
lysat
virus
except
rsv
purifi
viral
surfac
glycoprotein
use
antigen
rsv
eia
accord
publish
method
pair
serum
sampl
screen
singl
dilut
show
time
greater
optic
densiti
read
acut
convalesc
specimen
test
use
full
dilut
determin
antibodi
titer
serial
twofold
dilut
sampl
test
duplic
infect
defin
quadrupl
antibodi
baselin
week
antibodi
crossreact
infect
virus
distinguish
serolog
therefor
serolog
respons
antigen
design
analys
perform
use
sa
window
version
sa
institut
inc
cari
nc
chisquar
fisher
exact
test
use
compar
proport
mean
compar
use
student
ttest
independ
sampl
associ
clinic
ill
ye
number
viral
infect
diagnos
assess
use
mantelhaenszel
chisquar
statist
linear
associ
implement
sa
proc
freq
total
person
enrol
trial
complet
studi
pair
sera
avail
baselin
week
viral
analysi
differ
baselin
characterist
undergo
viral
test
statist
signific
data
shown
demograph
underli
medic
condit
also
similar
group
document
viral
infect
test
neg
viral
infect
tabl
overal
viral
infect
document
subject
thu
particip
least
one
viral
infect
studi
period
one
hundr
seventeen
subject
one
infect
two
infect
five
three
infect
one
evid
four
viral
infect
serolog
respons
eight
virus
document
studi
patient
hmpv
coronaviru
common
least
frequent
tabl
although
activ
individu
virus
vari
accord
year
studi
viral
infect
identifi
year
display
graphic
case
per
facil
year
figur
data
indic
complex
natur
viral
respiratori
diseas
nurs
home
except
two
facil
resid
test
posit
hmpv
one
facil
posit
rate
influenza
appear
predomin
singl
pathogen
within
nurs
home
rather
multitud
pathogen
circul
throughout
facil
year
observ
sera
collect
immedi
surround
ill
specif
etiolog
could
assign
individu
ill
analysi
clinic
data
show
signific
associ
serolog
diagnosi
viral
infect
occurr
bronchiti
p
pneumonia
p
lri
p
respiratori
infect
p
uri
p
accord
mantelhaenszel
chisquar
report
demonstr
wide
rang
respiratori
virus
circul
ltcf
previou
report
viral
diseas
popul
focus
primarili
outbreak
specif
virus
often
influenza
also
number
prospect
studi
examin
role
respiratori
virus
rsv
parainfluenza
nurs
home
limit
singl
season
institut
studi
uniqu
nurs
home
period
surveil
evalu
eight
differ
viral
infect
undertaken
although
trial
design
examin
specif
microbiolog
etiolog
respiratori
ill
collect
blood
baselin
year
provid
opportun
serolog
diagnosi
multipl
viral
infect
time
addit
wellrecogn
pathogen
influenza
rsv
infect
due
hmpv
coronavirus
parainfluenza
virus
identifi
throughout
studi
period
rather
larg
outbreak
singl
pathogen
verit
cornucopia
virus
circul
individu
nurs
home
year
rise
viralspecif
antibodi
accord
eia
remain
sensit
specif
detect
infect
respiratori
virus
elderli
peopl
even
compar
new
molecular
method
revers
transcript
polymeras
chain
reaction
rtpcr
sever
except
worth
note
one
influenza
respons
vaccin
may
complic
serolog
diagnosi
infect
current
studi
resid
diagnos
influenza
b
respect
none
subject
infect
influenza
show
antibodi
rise
influenza
b
vice
versa
suggest
antibodi
rise
vaccin
induc
addit
vaccin
effect
less
like
serum
sampl
obtain
month
immun
vaccin
induc
antibodi
typic
decreas
near
baselin
anoth
limit
serolog
viral
diagnosi
inabl
identifi
rhinoviru
rhinoviru
ubiquit
pathogen
shown
caus
outbreak
respiratori
diseas
nurs
home
serolog
diagnosi
possibl
multipl
serotyp
exist
rhinovirus
frequent
caus
common
cold
surpris
associ
found
uri
serolog
viral
diagnosi
present
limit
data
elderli
peopl
newli
describ
viru
hmpv
role
caus
ill
ltcf
outbreak
hmpv
infect
signific
morbid
mortal
ltcf
report
unit
state
canada
japan
report
diagnosi
made
use
rtpcr
number
document
case
small
studi
hmpv
common
infect
diagnos
account
document
viral
infect
asymptomat
serolog
infect
describ
young
elderli
adult
clinic
syndrom
assess
current
studi
therefor
true
effect
hmpv
could
assess
howev
frequenc
infect
indic
prospect
studi
hmpv
ltcf
need
similar
hmpv
coronavirus
difficult
detect
use
standard
viral
cultur
thu
data
avail
effect
virus
longterm
care
prospect
studi
nurs
home
unit
kingdom
use
serolog
diagnosi
acut
respiratori
infect
due
coronaviru
outbreak
respiratori
ill
due
coronaviru
mimick
influenza
also
describ
nurs
home
coronavirus
common
current
studi
account
infect
respect
two
new
strain
human
coronavirus
recent
identifi
requir
studi
determin
whether
virus
also
import
pathogen
popul
current
studi
demonstr
complex
natur
respiratori
tract
infect
ltcf
influenza
infect
identifi
resid
confirm
need
improv
influenza
vaccin
popul
yet
broad
rang
virus
circul
year
impress
underscor
import
viralspecif
diagnosi
outbreak
investig
clinic
trial
vaccin
antivir
data
provid
use
inform
wish
pursu
clinic
trial
relat
respiratori
viral
infect
nurs
home
popul
serolog
evid
viral
infect
nurs
home
